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Monday, March 7, 2011 261aIn lymphocytes Ca2þ signals are essential for diverse cellular functions. After
antigen binds to the T cell receptor a series of reactions are initiated that gen-
erate IP3 and culminate in an increase in cytosolic Ca
2þ. Mechanisms that re-
move Ca2þ also exert an important influence on the net Ca2þ level. The SERCA
pump resequesters Ca2þ into the ER and the PMCA transports Ca2þ to the ex-
tracellular side. Two key features of the PMCA are its stimulation by Ca2þ-cal-
modulin and by PKA-dependent phosphorylation (Bers, 2001) but in most of
the mathematical models this pump is represented with a simple Michaelis-
Menten formulation due to its small contribution to the overall Ca2þ fluxes.
This is not the case in T cells, Bautista et al (2002) showed that this pump is
the primary means of Ca2þ extrusion in T cells and its activity is modulated
by Ca2þ enabling the cell to adapt to higher Ca2þ values during T cell activa-
tion. Additionally once [Ca2þ]i returned to baseline levels the PMCA recovered
slowly with a time constant of ~ 4 min providing a ‘‘memory’’ of previous
[Ca2þ]i. We created a first order kinetics model of the PMCA that mimics its
activation and recovery as function of [Ca2þ]i (Vmax increased from 30 to
60 nM s1, Km decreased from 500 to 400 nM when fully activated) and incor-
porated into a mathematical description of Ca2þ signaling in T cells (Lympho-
LAB). Our results indicate that modulation of the PMCA activity improves the
stability of Ca2þ signaling by adjusting the pump rate to Ca2þ influx even at
high [Ca2þ]i levels (preventing a harmful Ca
2þ overload). Moreover the delay
in modulation permits small Ca2þ fluxes to increase transiently enhancing Ca2þ
signaling dynamics.1427-Pos Board B337
Potassium Channel Regulation of Thromboxane A2 Receptor Function
Shahab M. Danesh, Min Li, Enrico Stefani, Ligia Toro.
G-protein coupled receptors (GPCRs) and the large-conductance, voltage-
and Ca2þ -activated Kþ channel (MaxiK), are commonly expressed at the
plasma membrane of cells. GPCR activation results in activation or inhibition
of MaxiK channel activity depending on the type of GPCR. For example, ac-
tivation of Thromboxane A2 receptor leads to MaxiK channel inhibition. We
now investigate whether MaxiK channel alpha subunit (Slo1) can talk back
and regulate Thromboxane A2 receptor (TP) function. To this end, we ana-
lyzed two downstream processes of activated TP: activation of the mono-
meric G-protein Rho and stimulation of intracellular calcium release.
Expression of Slo1 in HEK293T cells increased Rho mediated transcriptional
activation of a Rho specific variant of the Serum Response Factor promoter
(SRE.L) by TP agonist, U46619 by 53% (P< 0.05). Accordingly, co-
expression of the Clostridium botulinum C3 transferase, a Rho inhibitor,
completely attenuated U46619 induced stimulation of SRE.L transcription.
Expression of the regulator of G-protein signaling domain domain of p115
rhoGEF (p115 rgRGS), a blocker of TP function, also resulted in 85%
(P<0.05) reduction in U46619 induced stimulation of SRE.L transcription.
Additionally, Slo1 expression increased TP mediated intracellular calcium re-
lease by 65% (P<0.05) and all intracellular calcium release was efficiently
blocked by addition of TP antagonist SQ 29,548. An increase in Rho and
Ca2þ pathways may lead to increased contraction in the vasculature where
thromboxane A receptor and MaxiK channels are expressed. Moreover, the
findings demonstrate a new paradigm in ion channel-GPCR signaling. Sup-
ported by NIH.
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Angiotensin II Type 1 receptor Associates with Maxik Channel Alpha Sub-
unit and Inhibits its Activity
Zhu Zhang, Min Li, Enrico Stefani, Ligia Toro.
Angiotensin II (Ang II) has a large impact in cardiovascular physiology
and serves as the most potent pharmacological target in the treatment of
hypertension. Most of the known physiological effects of Ang II are me-
diated by Angiotensin II type 1 receptor (AT1 receptor). AT1 receptor and
another transmembrane protein, the large conductance calcium-activated
potassium (MaxiK, BK) channel, both abundantly expressed in vascular
smooth muscle cells, are believed to play significant roles in regulating
vascular tone. Our present studies show that co-expression of AT1 receptor
with MaxiK channel results in inhibition of channel activity. AT1 receptor
expression produces a 13-mV or 32-mV rightward shift of voltage neces-
sary to half activate the channel (V1/2). AT1 receptor was also found in
co-immunoprecipitates (co-IP) with MaxiK a subunit (MaxiKa, Slo1) in
HEK293T cells expressing both proteins. Consistent with co-IP results,
a substantial co-localization of AT1 receptor and MaxiKa at the plasma
membrane was observed using live labeling and confocal microscopy. Fur-
thermore, the association of AT1 receptor with MaxiKa was dramatically
increased in response to Ang II stimulation. These results strongly suggest
a novel protein-protein interaction-based regulation of MaxiK channels byAT1 receptor, which will advance our understanding of GPCR-ion channel
interaction network on the fine regulation of vascular tone. Supported by
NIH.
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Nucleoside Diphosphate Kinase B Knockout Mice Have Impaired Activa-
tion of the Kþ channel KCa3.1 Resulting in Defective T Cell Activation
Shekhar Srivastava, Lie Di, Olga Zhdanova, Yi Sun, Zhai Li,
Edward Y. Skolnik.
Nucleoside Diphosphate kinases (NDPK) are encoded by the Nme (non-met-
astatic cell) gene family. While they comprise a family of 10 genes, NDPK-A
and B are ubiquitously expressed and account for most of the NDPK- activ-
ity. We previously showed that NDPK-B activates the Kþ channel KCa3.1
via histidine phosphorylation of the carboxyterminus of KCa3.1, which is
required for T cell receptor (TCR) stimulated Ca2þ flux and proliferation
of activated naive human CD4 T cells. We now report the phenotype of
NDPK-B-/- mice. NDPK-B-/- mice are phenotypically normal at birth with
a normal life span. Although T and B cell development is normal in
NDPK-B-/- mice, KCa3.1 channel activity and cytokine production is mark-
edly defective in T helper 1 (Th1) and Th2 cells, while Th17 function is nor-
mal. These findings phenocopy studies in the same cells isolated from
KCa3.1-/- mice and thereby supports genetically that NDPK-B functions up-
stream of KCa3.1. NDPK-A and B have been linked to an astonishing array
of disparate cellular and biochemical functions, few of which have been con-
firmed in vivo in physiological relevant systems. NDPK-B-/- mice will be an
essential tool to definitively address the biological functions of NDPK-B. Our
finding that NDPK-B is required for activation of Th1 and Th2 CD4 T cells,
together with the normal overall phenotype of NDPK-B-/- mice, suggests that
specific pharmacological inhibitors of NDPK-B may provide new opportuni-
ties to treat Th1 and Th2 mediated autoimmune diseases.
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Distinct Regulation of Slo1 Human Gene by Estrogen and Src
Shahab M. Danesh, Pallob Kundu, Enrico Stefani, Ligia Toro.
Estrogen Receptor Alpha (ERa) is a transcription factor for several genes
via genomic or non-genomic (signaling) mechanisms. We previously
showed that activated ERa induces transcription of the murine large-
conductance, voltage- and Ca2þ -activated Kþ channel (mSlo1) gene
through a genomic-dependent mechanism. Here, we analyzed whether
ERa transcribes humanSlo1 (hSlo1) gene. ERa transcription of the hSlo1
gene takes place at a much lower estrogen (E2) concentration
(EC50=0.07 nM) than for mSlo1 (EC50=0.4 nM), suggesting a different
mechanism of hSlo1 activation by ERa. Accordingly, disruption of the
DNA binding domain of ERa or knockdown of Sp1 protein as a potential
genomic mediator of ERa effect did not alter the up-regulation of hSlo1 in
response to E2. These results rule out direct and Sp-factor -and AP-1 fac-
tor- (absent in hSlo1 promoter)-mediated genomic action of ERa towards
hSlo1 transcription. To identify the non-genomic mechanism involved in
ERa transcriptional action, three candidate pathways (Rho, PI3 Kinase
(PI3K), and Src tyrosine kinase) were explored utilizing DNA binding do-
main mutant (DBDM) variant of ERa. Inhibition of Rho function by co-
expression of Clostridium toxin transferase (C3) had no effect on E2 action.
However, inhibition of PI3K activity with 10 mM LY294002 resulted in
a 44% decrease in E2-stimulated hSlo1 expression (P<0.05). Interestingly,
blockade of Src activity with 10 mM PP2 did not inhibit E2 action but
caused a 2 fold increase in the basal level of hSlo1 transcription to levels
attained with E2 activation (P<0.05). Conversely, constitutively active cSrc
(Y527F) completely abolished basal and E2 mediated activation of hSlo1
transcription. These results indicate that PI3K plays a role in E2 mediated
hSlo1 gene expression while Src activity does not mediate E2-induced
hSlo1 transcription but serves as a repressor of hSlo1 gene expression. Sup-
ported by NIH.
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Paxilline, a Closed BK Channel Blocker
Yu Zhou, Christopher J. Lingle.
The tremorogenic fungal metabolite, paxilline, is widely used as a potent and
relatively specific blocker of Ca2þ- and voltage-activated Slo1 (or BK) Kþ
channels. Little is known about the mechanism of paxilline blockade, although
paxilline has been proposed to act in an allosteric manner to influence the
closed-open equilibrium and block by paxilline has been shown to be Ca2þ -de-
pendent, with weakened block at more elevated Ca2þ. Our previous study
shows that block by paxilline is absolutely dependent on the presence of Gly-
cine311 in the BK S6 helix, suggesting that block may occur within the BK
262a Monday, March 7, 2011central cavity. Here we provide new tests of the mechanism of block by paxil-
line. We show that block by paxilline is inhibited in an approximately compet-
itive fashion by simultaneous application of the bulky pore blocker, bbTBA.
Furthermore, we show that a pore lining cysteine is protected from being mod-
ified by cytosolically applied MTSET once the channel is blocked by paxilline.
We also show that block is not strictly Ca2þ-dependent, but strongly linked to
channel open probability during paxilline application. By examining paxilline
blockade at different open probabilities defined by either transmembrane poten-
tial, Ca2þ, or chemical modifications, we show that paxilline only blocks closed
BK channels, with essentially no ability to block the BK channel once it is
open. We conclude that structural conformation of the BK channel necessary
for block of closed channels by paxilline are disrupted by mutation of G311.
The opening of the BK channel, which abolishes paxilline block, may produce
an S6 conformation similar to that induced by mutation of G311.
This work was supported by NIH grant GM-66215.
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Regulation of Intercellular Regulation of Signaling via Gap Junction
Yanyi Chen, Yubin Zhou, Hing-Cheung Wong, Xianming Lin, Qin Xu,
Xue Wang, Jie Jiang, Charles F. Louis, Richard Veenstra, Jenny J. Yang.
Gap junction, allowing the intercellular transmission of molecules through its
specialized cell membrane channels, plays a major role in intercellular calcium
signaling between adjacent cells. Connexin 43, 44 and 50 (Cx43, Cx44 and
Cx50) are members of the a family of gap junction proteins expressed in heart
and the lens of the eye where are essential for normal heart and lens develop-
ment. We have identified calmodulin (CaM) binding sites in Cx43, Cx44 and
Cx50. Biophysical results indicate that in the presence of calcium, synthesized
Cx peptide fragments encompassing predicted CaM binding regions are able to
bind with high affinity to CaM using NMR spectroscopy and fluorescence
method with dansylated CaM. In addition, electrophysiological studies demon-
strate that elevated intracellular Ca2þ concentration inhibits Cx50 gap junc-
tions with the 95% decline in junctional conductance (gj). Inclusion of either
CaM inhibitor or the designed CaM binding Cx peptide is able to prevent
this calcium-dependent inhibition of Cx50 gap junctions. Further, we have pre-
dicted several calcium binding pockets using our developed MUG algorithm.
We have further revealed the site-specific calcium binding capability of the pre-
dicted calcium binding site in gap junctions by grafting approach. Our results
elucidate the molecular mechanism of regulation of gap junction by both cal-
cium and calcium dependent CaM actions and provide insight into molecular
basis of human diseases.
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Use of a Gain-Of-Function BK Channel to Suppress Neural Excitability
Jenna R. Montgomery, Andrea L. Meredith.
BK channels have a uniquely large single channel conductance and are acti-
vated in physiological settings by coincident membrane depolarization and
rise in intracellular Ca2þ (Ca2þi). Increasing K
þ conductances, in many in-
stances, reduces neuronal activity. In this study we used a ‘gain-of-function’
BK channel as a tool to suppress neural excitability. We created a BK channel
construct with an Arginine (R) to Glutamine (Q) point mutation in the S4 volt-
age sensor. Previous studies in Xenopus oocytes with symmetrical Kþ solutions
showed that R207Q results in a significant negative shift in the channel’s
voltage-dependence of activation through reduced coupling between Ca2þ
binding and channel opening (Diaz et al, 1998). To address how this mutation
would affect excitability in mammalian cells under physiological conditions,
we recorded from inside-out patches excised from HEK293T cells at various
[Ca2þ]i. Wild-type (WT) BK and R207Q cDNAs were expressed separately
and together to form homo- and putative heterotetramers. Currents from
R207Q alone and WT/R207Q co-expression both display strong gain-of-
function properties in HEK cells under physiological conditions. The V0.5s
for WT, WT/R207Q and R207Q currents with nominal [Ca2þ]i were 113.5
53.5, 67.0 55.2 and 24.3 53.3 mV, respectively. In addition, currents re-
corded from R207Q- and WT/R207Q-expressing HEK cells with nominal
[Ca2þ]i activated faster than WT currents with 5 mM [Ca
2þ]i, at þ80 mV
(Tau activation=1.650.2, 2.150.2 and 5.852.6 ms, respectively). Overall,
WT/R207Q currents in the absence of Ca2þi were similar to WT currents with
50 mM Ca2þi. When an R207Q transgene was expressed in mouse hypotha-
lamic neurons with endogenous BK channels present, action potential fre-
quency was suppressed (WT: 33.353.2 versus R207Q: 65.557.3 Hz). This
work demonstrates that cells expressing R207Q channels have hyperactive
BK currents, resulting in suppression of neural activity under physiological
conditions.1434-Pos Board B344
Deficiency in the Functional Activity of BK Channels Leads to Systemic,
But Not Pulmonary, Hypertension
Yun-Min Zheng, Lindsay Larsen, Qiang Tang, Jun-Hua Xiao,
Chung-Fang Niu, Yong-Xiao Wang.
Big-conductance, Ca2þ-activated Kþ (BK) channels are important for the con-
trol of vascular tone in systemic arteries (SAs). Pulmonary arteries (PAs) are
very different in many aspects from SAs. Thus, this study was designed to de-
termine whether BK channels may show functional differences in these two
distinct circulation systems. Our data reveal that deficiency in BK channels
by targeted gene deletion of the channel b1 subunits leads to the significantly
elevated systemic, but not pulmonary, blood pressure. Using patch clamp re-
cordings, we have found that the activity of whole-cell and single BK channels
are significantly higher in systemic (cerebral) artery smooth muscle cells
(SASMCs) than in PASMCs. Similarly, the voltage and Ca2þ sensitivity of
BK channels are higher in SASMCs than in PASMCs. Real-time RT-PCR
and Western blotting experiments revealed that BK channel a subunit
mRNA and protein expression were comparable in CASMCs and PASMCs;
b1 subunit protein, but not its mRNA, expression is higher in SASMCs than
in PASMCs. Pharmacological inhibition of BK channels diminished
norepinephrine-induced increase in [Ca2þ]i in SASMCs, but not in PASMCs.
In summary, these findings provide the first evidence that the activity of BK
channels is higher in systemic (cerebral) than in pulmonary artery SMCs.
This heterogeneity is primarily determined by the differential functions and
molecular expression of b1 subunits. Moreover, pharmacological and genetic
data further verify the importance of heterogeneous functions of b1 subunits
in the regulation of cellular responses and blood pressure in systemic and pul-
monary circulation systems.
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Rab5- and Dynamin-Dependent Endocytosis of KCa2.3
Yajuan Gao, Daniel C. Devor.
We recently demonstrated that plasma membrane localized KCa2.3 is rapidly
recycled back to the cell surface in a Rab35/EPI64C and RME-1-dependent
manner following endocytosis. Herein, we report our initial studies designed
to elucidate the mechanism by which KCa2.3 is retrieved from the plasma
membrane. Using our recently described biotin ligase acceptor peptide-
tagged KCa2.3 construct, we demonstrate that overexpression of a dominant
active Rab5 (Q79L) results in the rapid colocalization of endocytosed
KCa2.3 with the Rab5-induced vacuoles. As expected if Rab5 is required
for the endocytosis of KCa2.3, overexpression of a dominant negative Rab5
(N133I) resulted in an approximately 2-fold accumulation of plasma mem-
brane channel, as assessed by biotinylation. Co-immunoprecipitation con-
firmed a close association between Rab5 and KCa2.3. As the Rab5-
dependent endocytic pathway can be either dynamin dependent or indepen-
dent we determined whether dynamin was required for the endocytosis of
KCa2.3. Overexpression of K44A dynamin resulted in an increase in
steady-state plasma membrane KCa2.3, relative to WT dynamin, consistent
with an inhibition of endocytosis. In addition, co-IP confirmed a close associ-
ation between KCa2.3 and dynamin. In total, our results suggest that the en-
docytosis of KCa2.3 is dependent upon Rab5 and dynamin.
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Dynamic Ubiquitination/Deubiquitination Regulates Plasma Membrane
KCa3.1 Endocytosis and Targeting to the Lysosomes
Corina M. Balut, Christian M. Loch, Daniel C. Devor.
We recently demonstrated that plasma membrane KCa3.1 is rapidly endocy-
tosed and targeted for lysosomal degradation via the ESCRT family of proteins.
In this study, we assess the role of ubiquitination in this process. Using a biotin-
ligase acceptor peptide tagged KCa3.1, which allows rapid biotinylation and
streptavidin labeling of the channel at the cell surface, in conjunction with tan-
dem ubiquitin-binding entities (TUBEs), which enable isolation of ubiquiti-
nated proteins, we demonstrate that KCa3.1 is heavily poly-ubiquitinated
following endocytosis. Further, by inhibiting channel endocytosis using hyper-
tonic sucrose, we demonstrate that KCa3.1 undergoes ubiquitination at the
plasma membrane. The role of ubiquitination in channel endocytosis was con-
firmed by treating the cells with the ubiquitin-activating enzyme (E1) inhibitor
UBEI-41, which dramatically reduced channel ubiquitination and inhibited its
internalization, as assessed by both confocal microscopy and pull-down assays.
To determine if KCa3.1 undergoes deubiquitination before delivery to the ly-
sosomes, we used the general deubiquitinating enzyme inhibitor PR619. This
induced a dramatic delay in channel degradation and an increased level of chan-
nel ubiquitination. Using the DUB-CHIP, a protein microarray impregnated
